Core Labs (CLB) Tops Q1 EPS by 1c; Guides Q2, FY11
Tweet
Share
E-mailGet Alerts CLB Hot Sheet
Price: $12.74 +2.82%
Financial Fact:
Income Tax Expense (Benefit): 2.08M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Income Tax Expense (Benefit): 2.08M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Core Laboratories NV (NYSE: CLB) reported Q1 EPS of $0.77, $0.01 better than the analyst estimate of $0.76. Revenue for the quarter came in at $206.73 million versus the consensus estimate of $202.34 million.
Sees Q2 sales of $215 - $220 million, versus $218.7 million. Sees EPS of 84-88c, vs. the consensus of 88c.
Sees FY11 sales of $890-$910 million, which compares to the Street estimate of $894.2 million. Sees EPS of $3.55-$3.60, vs. the consensus of $3.63.
Sees Q2 sales of $215 - $220 million, versus $218.7 million. Sees EPS of 84-88c, vs. the consensus of 88c.
Sees FY11 sales of $890-$910 million, which compares to the Street estimate of $894.2 million. Sees EPS of $3.55-$3.60, vs. the consensus of $3.63.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
- Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
